期刊文献+

(1R,2S)-2-(3,4-二氟苯基)环丙胺的制备方法

Preparation Method of( 1R,2S)-2-( 3,4-difluorophenyl)-cyclopropylamine
下载PDF
导出
摘要 制备(1R,2S)-2-(3,4-二氟苯基)环丙胺,优化制备工艺。以3,4-二氟溴苯为起始原料,经傅-克酰基化、立体选择性还原、环合、环丙烷化、水解、脱溴、酰胺化、霍夫曼消除共8步反应制备(1R,2S)-2-(3,4-二氟苯基)环丙胺。改进后的制备工艺所用原料和试剂工业上易得,价格低廉,操作方便,各步中间体易于纯化与储存,立体选择性较高,污染相对较小,环保压力小,易于工业上放大生产。 The preparation and optimization of( 1R,2S)-2-( 3,4-difluorophenyl)-cyclopropylamine were studied.( 1R,2S)-2-( 3,4-difluorophenyl)-cyclopropylamine was prepared from 3,4-difluoro- bromobenzene via eight steps including Friedel- crafts acylation,stereoselective reduction,cyclization,cyclopropanation,hydrolysis,debromination,amidation and Hoffman elimination. Not only the raw materials and reagents used in the improved process can be found easily in industry,but also the expenses were much lower. It can be found much easier when operating the reaction and purifying and storing the intermediates of each step. The stereo selectivity was higher with fewer wastes,it was more environmentally friendly. The improved process is more suitable for scale-up of industrial production.
作者 王伟 王彬彬
出处 《广州化工》 CAS 2015年第21期91-93,共3页 GuangZhou Chemical Industry
关键词 芳族环丙胺 制备方法 抗血凝 替格瑞洛 aromatic cyclopropylamine preparation method anticoagulation ticagrelor
  • 相关文献

参考文献5

  • 1Owen RT, Serradell N, Bolos J. AZD6140 [J]. Drugs Future, 2007, 32(10) : 845-853.
  • 2霍韶伟,郭晔堃,钟静芬,时惠麟.新型抗血小板药替卡格雷[J].上海医药,2012,33(3):21-23. 被引量:7
  • 3A·克拉克,E·琼斯,u·拉松,等.环丙基羧酸酯及其衍生物的制备方法[P].CN1211344C,2005-07-20.
  • 4M·米特素达,T·莫罗希马,K·苏库亚,等.用于制备光学活性环丙胺的方法[P].CNl01495444A,2009-07-29.
  • 5J.-P·德琼格,K·彼得斯,M·雷纳德.用于制备芳族环丙烷酯及酰胺的化学方法[P].CNl01495442A,2009-07-29.

二级参考文献5

  • 1Ghatak SB, Panchal SJ. Ticagrelor : a novel player in the field of anti-platelet therapy [J ]. J Pharm Res, 2010, 3(6) : 1271-1273.
  • 2Serebruany VL. Adenosine release : a potential explanation for the benefits of ticagrelor in the PLATelet Inhibition and Clinical Outcomes trial [ J ]. Am Heart J, 2011, 161(1) : 1-4.
  • 3Peters G, Robbie G. Single-dose pharmacokinetics and pharmacodynamics of AZD 6140-an oral reversible ADP receptor antagonist [ J ]. Haematologica, 2004, 89(Supp1 7) : 14-15.
  • 4Husted S, Emanuelsson H, Heptinstall S, et al. Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD 6140 with aspirin in patients with atherosclerosis : a double-blind comparison to clopidogrel with aspirin [ J ]. Eur Heart J, 2006, 27(9) : 1038-1047.
  • 5余佩毅,郭文.抗血小板新药替卡格雷临床应用争议[J].世界临床药物,2010,31(5). 被引量:5

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部